Pacemaker prevents fainting among select patient population

March 26, 2012, American College of Cardiology

A select number of patients who suffer from neurally mediated synope (NMS) – a disorder in which the brain fails to regulate heart rate and blood pressure – may be good candidates to receive a dual-chamber pacemaker to prevent common NMS-related fainting spells, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field.

NMS is often benign; however, some have few, if any, warning signs or symptoms before an impending attack, which can result in repeated falls and make tasks like driving or operating machinery dangerous.

The use of cardiac pacing to prevent fainting has been controversial: two earlier studies have shown that pacemakers do not benefit patients who suffer from NMS because of severe hypotensive reflex, or a dramatic drop in upon standing or tilting. Unlike these, the present Third International Study on Syncope of Uncertain Etiology (ISSUE-3) trial looked at the use of pacemakers among older patients who had severe asystolic NMS, which is not affected by fluctuations in blood pressure. Among these patients, a reduced the relative risk of suffering another fainting episode by 57 percent.

"We found that approximately one out of three pacemaker patients will benefit from pacing therapy within the subsequent two years," said Michele Brignole, MD, head of cardiology at the Arrhythmologic Centre, Ospedali Tigullio in Lavagna, Genoa and the study's lead investigator. "Cardiac pacing therapy is effective in reducing syncopal recurrences in this highly selected population."

The study took place in 51 centers, and involved 511 patients over age 40 who had suffered more than three NMS episodes in the previous two years. Doctors used an implantable loop recorder (ILR), a device that acts like a mini-EKG, to record and determine the cause of fainting. Of the 511 patients, 77 of them had a spontaneous asystolic syncope and were implanted with a pacemaker that was randomly selected to the "on" or "off" position. The study's endpoint was fainting reoccurrence.

Fifty-seven percent of the patients who had pacemakers set to the "off" position had a fainting reoccurrence within two years, but only 25 percent of patients with an activated pacemaker suffered a syncope.

As researchers continue to study asystolic fainting, pacemakers may be useful for patients whose NMS impedes daily life and is very unpredictable.

"We estimate that approximately 40 percent of ISSUE-3-like patients receiving an ILR will eventually be candidates for pacemaker therapy within four years," Dr. Brignole said. Dr. Brignole said that younger patients with NMS often suffer a more benign form of the disorder and respond to less drastic treatments, like physical counter-pressure maneuvers.

"The fact that pacing is effective does not mean that it is also always necessary," Dr. Brignole added.

"Cardiac pacing should be a last choice in highly selected patients affected by severe NMS."

Dr. Brignole said a better measurement of a pacemaker's effectiveness would be a study that uses the long-term syncope burden, not the first syncope occurrence, as a study endpoint.

Explore further: Pacemaker implantation for heart failure does not benefit nearly half of the patients

Related Stories

Pacemaker implantation for heart failure does not benefit nearly half of the patients

June 13, 2011
A new meta-analysis study, led by physician researchers at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine, and to be published in the Archives of Internal Medicine, shows ...

Study shows fainting factor in cardiac arrests

February 9, 2012
A new study by Dr. Andrew Krahn shows that over a quarter of unexplained cardiac arrests occurred after the patient had an event of fainting, known as syncope. According to Dr. Krahn, a Cardiologist at London Health Sciences ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.